我国创新药IND审批正式迈入30天高效时代，该公司已布局

Macro Strategy Highlights - The market consensus has been strong since August, with industry rotation intensity showing a seasonal decline, while September is traditionally a window for upward industry rotation intensity [1] - As the third-quarter report disclosure period approaches in late September to October, the correlation between stock prices and performance will gradually increase, marking a phase of enhanced effectiveness for cyclical investments [1] - Key areas to focus on include Hong Kong internet stocks, innovative pharmaceuticals, and new energy sectors, which are expected to benefit from interest rate cuts and industry catalysts [1][2][3] Industry Tracking - The Hong Kong internet sector is positioned to benefit from interest rate cuts and AI expansion, with platforms that have the best social scenarios and ecosystems likely to see early gains [1] - The innovative pharmaceutical sector has reached a moderate level of crowding, with sentiment sufficiently digested, and is expected to see catalysts from industry conferences in September and Q4 [1] - The new energy sector is driven by technological breakthroughs and anti-involution trends, providing a flexible new direction [2] - The new consumption sector has high odds currently, with seasonal catalysts and improved cyclical expectations enhancing success rates [3] - The cyclical sectors, particularly non-ferrous metals and chemicals, are experiencing multiple catalysts, with leading chemical companies showing a high safety margin in valuations [3]